Signaling from p53 to NF-kappa B determines the chemotherapy responsiveness of neuroblastoma.

Neoplasia (New York, N.Y.)

Volumn 8, Issue 11, 2006, Pages 964-974

  Armstrong, Michael B ^a   Bian, Xin ^a   Liu, Yihong ^a   Subramanian, Chitra ^a   Ratanaproeksa, Anthony B ^a   Shao, Feng ^a   Yu, Victor C ^a   Kwok, Roland P S ^a   Opipari, Anthony W ^a   Castle, Valerie P ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53;

ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; DRUG RESISTANCE; GENETICS; HUMAN; METABOLISM; NEUROBLASTOMA; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HUMANS; NEUROBLASTOMA; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33947544437     PISSN: None     EISSN: 14765586     Source Type: Journal    
DOI: None     Document Type: Article

References (0)